A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.

作者: Mai Shibata , Junko Toyoshima , Yuichiro Kaneko , Kazuo Oda , Tetsuya Nishimura

DOI: 10.1007/S00228-020-02876-2

关键词: Organic cation transport proteinsUrinePharmacologyRenal physiologyMetforminRheumatoid arthritisMetaboliteCmaxMedicinePharmacokinetics

摘要: … of peficitinib on … peficitinib and H2 (the metabolite of peficitinib with the highest exposure) with the human metformin transporters OCT1, OCT2, MATE1 and MATE2-K in vitro. Peficitinib …

参考文章(25)
Sung Kweon Cho, Choon Ok Kim, Eun Seok Park, Jae-Yong Chung, Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers British Journal of Clinical Pharmacology. ,vol. 78, pp. 1426- 1432 ,(2014) , 10.1111/BCP.12476
Richat Abbas, Joseph Boni, Daryl Sonnichsen, Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects. Drug metabolism and personalized therapy. ,vol. 30, pp. 57- 63 ,(2015) , 10.1515/DMDI-2014-0026
Yan Shu, Steven A. Sheardown, Chaline Brown, Ryan P. Owen, Shuzhong Zhang, Richard A. Castro, Alexandra G. Ianculescu, Lin Yue, Joan C. Lo, Esteban G. Burchard, Claire M. Brett, Kathleen M. Giacomini, Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. Journal of Clinical Investigation. ,vol. 117, pp. 1422- 1431 ,(2007) , 10.1172/JCI30558
Li Gong, Srijib Goswami, Kathleen M. Giacomini, Russ B. Altman, Teri E. Klein, Metformin pathways: pharmacokinetics and pharmacodynamics Pharmacogenetics and Genomics. ,vol. 22, pp. 820- 827 ,(2012) , 10.1097/FPC.0B013E3283559B22
Kelli H. Boxberger, Bruno Hagenbuch, Jed N. Lampe, Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake. Drug Metabolism and Disposition. ,vol. 42, pp. 990- 995 ,(2014) , 10.1124/DMD.113.055095
John J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, Yoshiya Tanaka, Arian Laurence, Janus kinase inhibitors in autoimmune diseases Annals of the Rheumatic Diseases. ,vol. 72, ,(2013) , 10.1136/ANNRHEUMDIS-2012-202576
Y Shu, C Brown, RA Castro, RJ Shi, ET Lin, RP Owen, SA Sheardown, L Yue, EG Burchard, CM Brett, KM Giacomini, Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clinical Pharmacology & Therapeutics. ,vol. 83, pp. 273- 280 ,(2008) , 10.1038/SJ.CLPT.6100275
Faith Matcham, Ian C. Scott, Lauren Rayner, Matthew Hotopf, Gabrielle H. Kingsley, Sam Norton, David L. Scott, Sophia Steer, The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism. ,vol. 44, pp. 123- 130 ,(2014) , 10.1016/J.SEMARTHRIT.2014.05.001
Iain B McInnes, Georg Schett, None, The pathogenesis of rheumatoid arthritis. The New England Journal of Medicine. ,vol. 365, pp. 2205- 2219 ,(2011) , 10.1056/NEJMRA1004965